[
  {
    "info": {
      "NCT": "NCT02428712",
      "Protocol_No": "PLX120-03",
      "jit": "Caris",
      "trial_name": "Fore Biotherapeutics "
    },
    "disease": {
      "summary": "Advanced Unresectable Solid Tumors, BRAF-mutated Tumors",
      "details": [
        {
          "code": "Bowel (BOWEL)",
          "selection": "exclude",
          "stage": "NA"
        },
        {
          "code": "Glioma",
          "selection": "include",
          "stage": "NA"
        },
        {
          "code": "High-Grade Glioma, NOS (HGGNOS)",
          "selection": "include",
          "stage": "NA"
        },
        {
          "code": "Low-Grade Glioma, NOS (LGGNOS)",
          "selection": "include",
          "stage": "NA"
        },
        {
          "code": "Pancreas (PANCREAS)",
          "selection": "exclude",
          "stage": "NA"
        },
        {
          "code": "Solid Tumors",
          "selection": "include",
          "stage": "Un-resectable;Advanced Stage"
        }
      ]
    },
    "query": {
      "nct": "NCT02428712",
      "title": "A Study of FORE8394 as a Single Agent in Patients With Advanced Unresectable Solid Tumors",
      "current_status": "Recruiting",
      "status_verif_date": "July 2022",
      "last_update_date": "July 15, 2022",
      "trial_hold_status": "open (JIT)",
      "sponsor": "Fore Biotherapeutics",
      "brief_summary": "The objective of this study is to determine the safety, pharmacokinetics, maximum tolerated dose/recommended Phase 2 dose, and efficacy of FORE8394.",
      "conditions": "Advanced Unresectable Solid Tumors | BRAF-mutated Tumors",
      "type": "Interventional",
      "phase": "Phase 1 | Phase 2",
      "arm": [
        {
          "ArmID": "1",
          "cohortlabel": "FORE8394",
          "drug": "FORE8394",
          "arm_type": "Experimental",
          "line_of_therapy": "Not available",
          "arm_hold_status": "open",
          "biomarker": [
            {
              "cohort": "FORE8394",
              "Gene": "HRAS",
              "Gene2": "Not available",
              "Type": "Mutation",
              "Variant": "Not available",
              "Selection": "exclude",
              "Function": "Not available",
              "summary": "HRAS Mutation  "
            },
            {
              "cohort": "FORE8394",
              "Gene": "NRAS",
              "Gene2": "Not available",
              "Type": "Mutation",
              "Variant": "Not available",
              "Selection": "exclude",
              "Function": "Not available",
              "summary": "NRAS Mutation  "
            },
            {
              "cohort": "FORE8394",
              "Gene": "KRAS",
              "Gene2": "Not available",
              "Type": "Mutation",
              "Variant": "Not available",
              "Selection": "exclude",
              "Function": "Not available",
              "summary": "KRAS Mutation  "
            },
            {
              "cohort": "FORE8394",
              "Gene": "RTK",
              "Gene2": "Not available",
              "Type": "Mutation",
              "Variant": "Not available",
              "Selection": "exclude",
              "Function": "activating",
              "summary": "RTK Mutation activating  "
            },
            {
              "cohort": "FORE8394",
              "Gene": "BRAF",
              "Gene2": "Not available",
              "Type": "Mutation",
              "Variant": "V600",
              "Selection": "include",
              "Function": "activating",
              "summary": "BRAF V600 Mutation activating "
            }
          ]
        }
      ],
      "docs": "<a href=\"https://trialplus.carisls.com/\" target=\"_blank\">Caris<\/a>",
      "locations": "Sioux Falls SD",
      "doclastupdate": "2023-01-17",
      "min_age": "10 Years",
      "gender": "All",
      "link": "<a href=\"https://clinicaltrials.gov/ct2/show/NCT02428712\" target=\"_blank\">NCT02428712<\/a>"
    }
  }
]
